Gene · 1890
Papers4,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A comprehensive review on pharmacological applications and drug-induced toxicity of valproic acid. | Saudi Pharm J | 2023 | 36942277 | PubTator, text mining | PubMed |
| Transcriptomes of the tumor-adjacent normal tissues are more informative than tumors in predicting recurrence in colorectal cancer patients. | J Transl Med | 2023 | 36941605 | PubTator, text mining | PubMed |
| Plasma proteomic and metabolomic signatures of B-ALL patients during CAR-T cell therapy. | Clin Transl Med | 2023 | 36938989 | PubTator, text mining | PubMed |
| Case report: Long-term survival in a patient with metastatic colorectal cancer treated with trifluridine/tipiracil in the third-line setting. | Front Oncol | 2023 | 36937418 | PubTator, text mining | PubMed |
| Metabolic crosstalk between stromal and malignant cells in the bone marrow niche. | Bone Rep | 2023 | 36909665 | PubTator, text mining | PubMed |
| Resveratrol Modulates Chemosensitisation to 5-FU via β1-Integrin/HIF-1α Axis in CRC Tumor Microenvironment. | Int J Mol Sci | 2023 | 36902421 | PubTator, text mining | PubMed |
| Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis. | Brain | 2023 | 36864689 | PubTator, text mining | PubMed |
| Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer. | Nat Med | 2023 | 36864254 | PubTator, text mining | PubMed |
| Angiogenesis in abnormal uterine bleeding: a narrative review. | Hum Reprod Update | 2023 | 36857162 | PubTator, text mining | PubMed |
| The feasibility and safety of eustachian tube dilation with a standard endovascular balloon: a clinical pilot study. | J Otolaryngol Head Neck Surg | 2023 | 36855202 | PubTator, text mining | PubMed |
| RNA-seq reveals novel mechanistic targets of Livin in bladder cancer. | BMC Urol | 2023 | 36855119 | PubTator, text mining | PubMed |
| Proteomic analysis identifies dysregulated proteins and associated molecular pathways in a cohort of gallbladder cancer patients of African ancestry. | Clin Proteomics | 2023 | 36855072 | PubTator, text mining | PubMed |
| Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets. | Kidney Blood Press Res | 2023 | 36854280 | PubTator, text mining | PubMed |
| Construction of a prognostic prediction model for renal clear cell carcinoma combining clinical traits. | Sci Rep | 2023 | 36849551 | PubTator, text mining | PubMed |
| Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments. | World J Gastroenterol | 2023 | 36844139 | PubTator, text mining | PubMed |
| Structural and Molecular Basis for Mitochondrial DNA Replication and Transcription in Health and Antiviral Drug Toxicity. | Molecules | 2023 | 36838782 | PubTator, text mining | PubMed |
| Cycloguanil and Analogues Potently Target DHFR in Cancer Cells to Elicit Anti-Cancer Activity. | Metabolites | 2023 | 36837770 | PubTator, text mining | PubMed |
| In Vitro and Predictive Computational Toxicology Methods for the Neurotoxic Pesticide Amitraz and Its Metabolites. | Brain Sci | 2023 | 36831795 | PubTator, text mining | PubMed |
| Unique Metabolic Contexts Sensitize Cancer Cells and Discriminate between Glycolytic Tumor Types. | Cancers (Basel) | 2023 | 36831501 | PubTator, text mining | PubMed |
| In Vivo Acute Toxicity Studies of Novel Anti-Melanoma Compounds Downregulators of hnRNPH1/H2. | Biomolecules | 2023 | 36830718 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1890/papers?page=18